United States · FDA National Drug Code directory

Cyclobenzaprine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0115-1437_8e7da23f-dda8-4834-91ae-0691668d1374
Product NDC: 0115-1437
Form: CAPSULE, EXTENDED RELEASE
Composition / generic term: Cyclobenzaprine Hydrochloride
Labeler: Amneal Pharmaceuticals of New York LLC
Marketing category: NDA AUTHORIZED GENERIC
Marketing start / end (source format): 20190301
Source listing expiry: 20261231

Source-listed ingredients

CYCLOBENZAPRINE HYDROCHLORIDE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1437-13) · 0115-1437-13

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →